{{Rsnum
|rsid=12617313
|Gene=EPAS1
|Chromosome=2
|position=46332637
|Orientation=plus
|GMAF=0.3219
|Gene_s=EPAS1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 24.8 | 55.8 | 19.5
| HCB | 0.7 | 2.9 | 96.4
| JPT | 0.0 | 5.3 | 94.7
| YRI | 11.6 | 47.6 | 40.8
| ASW | 19.3 | 49.1 | 31.6
| CHB | 0.7 | 2.9 | 96.4
| CHD | 0.9 | 4.6 | 94.5
| GIH | 20.8 | 51.5 | 27.7
| LWK | 0.9 | 39.1 | 60.0
| MEX | 3.4 | 46.6 | 50.0
| MKK | 11.5 | 50.0 | 38.5
| TSI | 41.2 | 47.1 | 11.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=22113997
|Title=The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma
|OA=1
}}

{{on chip | Affy GenomeWide 6}}